Antibodies, markers, reagents and recent reviews of their applications, links to conferences. Online catalog and purchase available from Cambridge, England and Massachusetts.

Developing therapies for the treatment of bone defects and myocardial regeneration, based on somatic stem cells, isolated from cord blood. Investor data and overview of company in Langenfeld, Germany.

Offers lines of normal human embryonic stem cells, and genetically abnormal variants to scientists and researchers. with sub-licensing to commercial and scientific institutions from London, UK.

Offers stem cell researchers a method of opening the zona for insertion or withdrawal of genetic material. From Hamilton Thorne Biosciences Inc., Beverly, Massachusetts.

Company conducts research using autologous human cells in a serum free medium to treat incurable diseases. The results propose possible new treatments for regeneration of diseased tissues. Based in Geneva, Switzerland.

Specializing initially in hematopoietic stem cells and developing expansion from umbilical cord blood using its proprietary bioreactor and 3-D technology platform. Includes investor data and overview of company in Haifa, Israel.

Developing therapy by the transplantation of the patient's own cell-line after isolation and processing in vitro, to replace, repair or enhance the function of damaged tissues. Clinical trials based in Bangkok, Thailand and Kiryat Weizmann, Israel.

Offers ISO 17025 compliant storage of stem cells derived from the bone marrow, and associated testing in Harrow, England.

Developing somatic transplantation technology for diabetes, neuronal degeneration and therapy for brain damage including stroke, Parkinson's disease, Alzheimer's and Huntington's disease. Overview of company in Guildford, England.

Research and development of retrodifferentiation technology, used to create stem cells from mature adult cells. Includes technological and corporate overview, with FAQ and contacts in London, UK.